haloperidol and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

haloperidol has been researched along with n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartenstein, P; Chowdhury, S; Djurova, P; Fricker, G; Höfner, G; Purisima, EO; Schirrmacher, R; Wängler, B; Wängler, C; Wanner, KT1
Christian, BT; Mantil, J; Mukherjee, J; Narayanan, TK; Shi, B1
Ansari, MS; Dawant, B; Jayathilake, K; Kessler, RM; Li, R; Meltzer, HY; Riccardi, P1
Bertolino, A; Dipasquale, O; Dukart, J; Hawkins, PCT; Mehta, MA; Pergola, G; Rizzo, G; Sambataro, F; Selvaggi, P; Turkheimer, F; Veronese, M; Williams, SCR; Zelaya, F1

Trials

2 trial(s) available for haloperidol and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

ArticleYear
Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:12

    Topics: Adult; Antipsychotic Agents; Benzamides; Benzodiazepines; Brain Chemistry; Corpus Striatum; Dopamine Antagonists; Female; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Pyrimidinones; Pyrrolidines; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D3; Schizophrenia; Serotonin Antagonists

2005
Increased cerebral blood flow after single dose of antipsychotics in healthy volunteers depends on dopamine D2 receptor density profiles.
    NeuroImage, 2019, Volume: 188

    Topics: Adult; Antipsychotic Agents; Benzamides; Brain; Cerebrovascular Circulation; Cross-Over Studies; Dopamine D2 Receptor Antagonists; Double-Blind Method; Fluorine Radioisotopes; Haloperidol; Healthy Volunteers; Humans; Olanzapine; Positron-Emission Tomography; Receptors, Dopamine D2; Risperidone; RNA, Messenger; Spin Labels

2019

Other Studies

2 other study(ies) available for haloperidol and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

ArticleYear
Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding?
    Journal of medicinal chemistry, 2014, May-22, Volume: 57, Issue:10

    Topics: Amino Acid Sequence; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Transport; Blood-Brain Barrier; Carrier Proteins; Dopamine Antagonists; Humans; Ligands; Models, Molecular; Molecular Docking Simulation; Molecular Sequence Data; Receptors, Dopamine D2; Receptors, Transferrin; Transcytosis

2014
Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 25, Issue:4

    Topics: Animals; Antipsychotic Agents; Autoradiography; Benzamides; Brain; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Haloperidol; Macaca mulatta; Male; Neostriatum; Pyrrolidines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Risperidone; Tomography, Emission-Computed

2001